TI
VKTX icon

Trexquant Investment’s Viking Therapeutics VKTX Stock Holding History

Trexquant Investment’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Buy
112,499
+89,771
+395% +$2.9M 0.03% 813
2026
Q1 		$740K Buy
+22,728
New +$731K 0.01% 1333
2025
Q4 		– Sell
-140,531
Closed -$3.69M – 1954
2025
Q3 		$3.69M Sell
140,531
-69,897
-33% -$2.09M 0.04% 664
2025
Q2 		$5.58M Buy
+210,428
New +$5.54M 0.06% 490
2025
Q1 		– Sell
-64,908
Closed -$2.61M – 1897
2024
Q4 		$2.61M Buy
+64,908
New +$3.7M 0.03% 769
2024
Q3 		– Sell
-51,296
Closed -$2.72M – 1890
2024
Q2 		$2.72M Buy
+51,296
New +$3.36M 0.04% 626
2023
Q4 		– Sell
-84,147
Closed -$932K – 1823
2023
Q3 		$932K Sell
84,147
-182,172
-68% -$2.61M 0.02% 781
2023
Q2 		$4.32M Buy
266,319
+197,394
+286% +$4.14M 0.11% 248
2023
Q1 		$1.15M Sell
68,925
-41,489
-38% -$429K 0.03% 682
2022
Q4 		$1.04M Buy
+110,414
New +$493K 0.03% 627
2022
Q1 		– Sell
-18,714
Closed -$86K – 1758
2021
Q4 		$86K Buy
18,714
+84
+0.5% +$471 0.01% 1244
2021
Q3 		$117K Sell
18,630
-2,671
-13% -$16.5K 0.01% 1036
2021
Q2 		$128K Buy
+21,301
New +$126K 0.01% 992
2021
Q1 		– Sell
-19,721
Closed -$111K – 1500
2020
Q4 		$111K Sell
19,721
-41,702
-68% -$253K 0.01% 960
2020
Q3 		$357K Buy
+61,423
New +$423K 0.02% 850
2018
Q2 		– Sell
-64,413
Closed -$281K – 1248
2018
Q1 		$281K Buy
+64,413
New +$356K 0.02% 835

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Trexquant Investment's VKTX Position: Q2 2026 in Review

Trexquant Investment increased its Viking Therapeutics (VKTX) stake by 395% in Q2 2026, buying an estimated $2.9M and bringing the position to 112,499 shares worth $4.39M. The position accounts for 0.03% of the portfolio, ranked #813.

Trexquant Investment first reported a position in VKTX in Q1 2018 and has held it in 16 quarters since. The position peaked at $5.58M in Q2 2025. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Trexquant Investment held 112,499 shares of Viking Therapeutics worth $4.39M as of Q2 2026.
  • Trexquant Investment bought 89,771 Viking Therapeutics shares in Q2 2026, an estimated $2.9M.
  • Viking Therapeutics made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #813 holding.
  • Trexquant Investment first reported a position in Viking Therapeutics in Q1 2018 and has held it in 16 quarters since.
  • Trexquant Investment's Viking Therapeutics position peaked at $5.58M in Q2 2025.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.